Edralbrutinib
Edralbrutinib (TG-1701) is a potent BTK inhibitor with anticancer activity used in treating tumors, immune system disorders, and blood and lymphatic system disorders. Additionally, Edralbrutinib is studied for its efficacy in membranous glomerulonephritis and optic neuromyelitis optica.
Product Specifications
CAS Number
1858206-58-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
489.47
Molecular Formula
C26H21F2N5O3
Notes
Research use only, not for human use.
Receptor
BTK
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog